Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Projects and priorities in cardiovascular modeling.

M A Hlatky1, H P Selker

  • 1Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.

Journal of the American College of Cardiology
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply: proton-pump inhibitor use and the risk of first-time ischemic stroke in the general population.

Journal of internal medicine·2017
Same author

Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.

Journal of internal medicine·2017
Same author

PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms.

Clinical pharmacology and therapeutics·2016
Same author

Common variants associated with changes in levels of circulating free fatty acids after administration of glucose-insulin-potassium (GIK) therapy in the IMMEDIATE trial.

The pharmacogenomics journal·2015
Same author

The next frontier: Fostering innovation by improving health data access and utilization.

Clinical pharmacology and therapeutics·2015
Same author

Genetic modifiers of response to glucose-insulin-potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial.

The pharmacogenomics journal·2015

This study reviews clinical decision models. Key areas for improvement include standardization, accessibility, validation, and dissemination of these important medical decision tools.

Area of Science:

  • Health Informatics
  • Clinical Decision Making
  • Biostatistics

Background:

  • Existing studies model clinical outcomes based on patient characteristics or analyze factors influencing medical decisions.
  • Current decision models offer significant contributions to healthcare.
  • A 1987 Regenstrief Conference working group identified areas needing further development in decision modeling.

Purpose of the Study:

  • To discuss improvements for clinical decision models.
  • To address limitations in current decision-making tools.
  • To enhance the utility and application of predictive models in medicine.

Main Methods:

  • Review of studies modeling clinical outcomes and medical decision factors.
  • Discussion of recommendations from a 1987 Regenstrief Conference working group.

Related Experiment Videos

  • Analysis of key areas for advancing decision model development and implementation.

    • Main Results:

    • Identification of critical areas for enhancing decision models.
    • Focus on improving standardization across different models.
    • Highlighting the need for better accessibility, validation, and dissemination strategies.

    Conclusions:

    • Standardization, accessibility, validation, and dissemination are crucial for advancing clinical decision models.
    • Further attention is required to optimize the impact of these models in healthcare.
    • Improving these aspects will enhance the reliability and usability of medical decision support tools.